Literature DB >> 28481393

Differential Expression of microRNAs in Medulloblastoma and the Potential Functional Consequences.

Yuting Zhang1, Lusheng Li, Ping Liang, Xuan Zhai, Yingliang Li, Yudong Zhou.   

Abstract

AIM: To identify differentially expressed microRNAs in medulloblastoma, and to investigate their biological function.
MATERIAL AND METHODS: Differentially expressed microRNAs were identified using gene chips, and significantly different microRNAs were selected for verification using real time quantitative PCR. Potential target genes and their biological pathways were predicted by bioinformatics software.
RESULTS: Our analysis identified two microRNAs, hsa-miR-208a-3p and hsa-miR-1207-5p, which were significantly downregulated in medulloblastoma. Bioinformatics analysis identified potential target genes in the Wnt and MAPK signaling pathways, including NLK, RAPGEF2, CACNA2D1, DUSP3, MAPK8IP3.
CONCLUSION: Downregulation of hsa-miR-208a-3p and hsa-miR-1207-5p may be involved in the occurrence of medulloblastoma, through modulations of the Wnt and MAPK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28481393     DOI: 10.5137/1019-5149.JTN.19379-16.2

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  3 in total

Review 1.  Emerging roles for multifunctional ion channel auxiliary subunits in cancer.

Authors:  Alexander S Haworth; William J Brackenbury
Journal:  Cell Calcium       Date:  2019-04-25       Impact factor: 6.817

2.  Dysregulated circular RNAs in medulloblastoma regulate proliferation and growth of tumor cells via host genes.

Authors:  Tao Lv; Yi-Feng Miao; Ke Jin; Shuo Han; Tian-Qi Xu; Zi-Long Qiu; Xiao-Hua Zhang
Journal:  Cancer Med       Date:  2018-11-06       Impact factor: 4.452

3.  LncRNA-PVT1 indicates a poor prognosis and promotes angiogenesis via activating the HNF1B/EMT axis in glioma.

Authors:  Yongyan Bi; Jie Ji; Youxin Zhou
Journal:  J Cancer       Date:  2021-07-25       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.